Farms.com Home   News

Grain Markets Continue To See Strong Demand

Farmers are busy with spring seeding operations.

Over the last few weeks they've seen continued strength in the markets with increases on the futures board up by close to 21% for canola, 23% for corn and hard red spring wheat up by about 23%.

Brennan Turner, CEO of Combyne Ag says the bottom line is that we've got a really, really strong demand function right now.

'With COVID there's been supply constraints or supply chain concerns, some tighter carryouts than what I think a lot of people were expecting. Smaller crops than what we were kind of anticipating back in the fall, and all of this combined with the fact that there are some moisture concerns to start the new crop growing season. This is just amplifying prices to a level that we haven't seen. I mean for corn and soybeans, we haven't seen this prices for eight years for hard red spring wheat. We haven't seen these prices since 2017 and for canola, obviously, it's been a couple of years since canola prices have been up near the $20 a bushel."

He notes it's a combination of some weather concerns, but mostly demand right now and there's a lot weighing on the upcoming growing season.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.